Marty Makary will remain FDA Commissioner past June 2026

Makary's testimony to the Senate Appropriations Committee on May 14, 2025, signals strong institutional support. His replacement by a mainstream FDA insider (e.g., Kyle Diamantas) would require Trump to reverse his earlier firing decision, which is unlikely given recent policy alignment.

Implied probability (Yes)

70%